Browse > Article

Effects of MeOH Extract from Stem Bark of Plantocracy strobilacea on the Metabolism of Amyloid Precursor Protein in Neuroblastoma Cells  

Jiang, Gui Bao (College of Pharmacy, Woosuk University)
Leem, Jae Yoon (College of Pharmacy, Woosuk University)
Publication Information
Journal of Physiology & Pathology in Korean Medicine / v.27, no.1, 2013 , pp. 57-62 More about this Journal
Abstract
Alzheimer's disease (AD), one of the most common forms of dementia, is characterized pathologically by the presence of intracellular neurofibrillary tangles and deposition of ${\beta}$-amyloid ($A{\beta}$) peptides of 40-42 residues, which are generated by processing of amyloid precursor protein (APP). $A{\beta}$ has been believed to be neurotoxic and now is also considered to have a role on the mechanism of memory dysfunction. Here, we show that MeOH extract from stem bark of Platycarya strobilacea Sieb. et. Zucc. (PSM) affects on the processing of APP from the APPswe over-expressing Neuro2a cell line. We found that PSM may regulate the processing of APP and increase the sAPP${\alpha}$. PSM does not change the protein level of presenilin and nicastrin, however, it reduces the protein expression level of BACE1. In addition, PSM reduces the secretion level of $A{\beta}42$ and $A{\beta}40$ from the cell line without toxicity. We suggest that Platycarya strobilacea may be useful as a herbal medicine to treat Alzheimer's disease.
Keywords
Alzheimer's disease; ${\beta}$-amyloid peptides; Platycarya strobilacea; APPswe; BACE;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Vassar, R., Bennett, B.D., Babu-Khan, S., Kahn, S., Mendiaz, E.A., Denis, P., Teplow, D.B., Ross, S., Amarante, P., Loeloff, R., Luo, Y., Fisher, S., Fuller, J., Edenson, S., Lile, J., Jarosinski, M.A., Biere, A.L., Curran, E., Burgess, T., Louis, J.C., Collins, F., Treanor, J., Rogers, G., Citron, M. $\beta$-Secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science 286: 735-741, 1999.   DOI   ScienceOn
2 Selkoe, D.J. Translating cell biology into therapeutic advances in Alzheimer's disease. Nature 399: 23-31, 1999.   DOI   ScienceOn
3 Fu, H., Dou, J., Li, W., Cui, W., Mak, S., Hu, Q., Luo, J., Lam, C.S., Pang, Y., Youdim, M.B. and Han, Y. Promising multifunctional anti-Alzheimer's dimer bis(7)-Cognitin acting as an activator of protein kinase C regulates activities of alpha-secretase and BACE-1 concurrently. Eur. J. Pharmacol. 623(1-3):14-21, 2009.   DOI   ScienceOn
4 Yu, G., Nishimura, M., Arawaka, S., Levitan, D., Zhang, L., Tandon, A., Song, Y.Q., Rogaeva, E., Chen, F., Kawarai, T., Supala, A., Levesque, L., Yu, H., Yang, D.S., Holmes, E., Milman, P., Liang, Y., Zhang, D.M., Xu, D.H., Sato, C., Rogaev, E., Smith, M., Janus, C., Zhang, Y., Aebersold, R.,Farrer, L.S., Sorbi, S., Bruni, A., Fraser, P., St. George-Hyslop, P. Nicastrin modulates presenilin-mediated notch/glp-1 signal transduction and betaAPP processing. Nature 407: 48-54, 2000.   DOI   ScienceOn
5 Lee, S.F., Shah, S., Li, H., Yu, C., Han, W., Yu, G Mammalian APH-1 interacts with presenilin and nicastrin and is required for intramembrane proteolysis of amyloid-beta precursor protein and Notch. J. Biol. Chem. 277: 45013-45019, 2002.   DOI   ScienceOn
6 Steiner, H., Winkler, E., Edbauer, D., Prokop, S., Basset, G., Yamasaki, A., Kostka, M. and Haass, C. PEN-2 is an integral component of the $\gamma$-secretase complex required for coordinated expression of presenilin and nicastrin. J. Biol. Chem. 277: 39062-39061, 2002.   DOI   ScienceOn
7 Hardy, J. and Selkoe, D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297: 353-356, 2002.   DOI   ScienceOn
8 Cai, H., Wang, Y., McCarthy, D., Wen, H., Borchelt, D.R., Price, D.L., Wong, P.C. BACE1 is the major $\beta$-secretase for generation of A$\beta$ peptides by neurons. Nature Neurosci. 4: 233-234, 2001.   DOI   ScienceOn
9 Sugimoto, H. Donepezil hydrochloride. a treatment drug for Alzheimer's disease. Chem. Rec. 1: 63-73, 2001.   DOI   ScienceOn
10 Zarotsky, V., Sramek, J.J. and Cutler, N.R. Galantamine hydrobromide. an agent for Alzheimer's disease. Am. J. Health Syst. Pharm. 60: 446-452, 2003.
11 Jann, M.W. Rivastigmine, a new-generation cholinesterase inhibitor for the treatment of Alzheimer's disease. Pharmacotherapy. 20: 1-12, 2000.   DOI   ScienceOn
12 Babu, D., Lee, J.S., Park, S.Y., Thapa, D., Choi, M.K., Kim, A.R., Park, Y.J., Kim, J.A. Involvement of NF-kappaB in the inhibitory actions of Platycarya strobilacea on the TNF-alpha-induced monocyte adhesion to colon epithelial cells and chemokine expression. Arch Pharm Res. 31(6):727-735, 2008.   DOI
13 Kim, Y.H., Kim, K.H., Han, C.S., Yang, H.C., Park, S.H., Jang, H.I., Kim, J.W., Choi, Y.S., Lee, N.H. Anti-wrinkle activity of Platycarya strobilacea extract and its application as a cosmeceutical ingredient. J. Cosmet. Sci. 61(3):211-224, 2010.
14 Wang, R., Sweeney, D., Gandy, S.E. and Sissodia, S.S. The profile of soluble amyloid $\beta$ protein in cultured cell media. J. Biol. Chem. 271: 31894-31902, 1996.   DOI   ScienceOn
15 Tung, J.S., Davis, D.L., Anderson, J.P., Walker, D.E., Mamo, S., Jewett, N., Hom, R.K., Sinha, S., Thorsett, E.D., John, V. Design of substrate-based inhibitors of human beta-secretase. J. Med. Chem. 45: 259-262, 2002.   DOI   ScienceOn
16 김상태, 강형원, 한평림, 조형권, 김태헌, 류영수, 손형진. 壯元丸加減方인 LMK02가 아밀로이드 前驅蛋白質으로 形質轉換 된 초파리에 미치는 효과. 동의신경정신과학회지 19(2):151-163, 2008.
17 Leem, J.Y., Saura, C.A., Pietrzik, C., Christianson, J., Wanamaker, C., King, L.T., Veselits, M.L., Tomita, T., Gasparini, L., Iwatsubo, T., Xu, H., Green, W.N., Koo, E.H., Thinakaran, G. A role for presenilin 1 in regulating the delivery of amyloid precursor protein to the cell surface. Neurobiol. Dis. 11: 64-82, 2002.   DOI   ScienceOn
18 Iqbal, K., Sisodia, S.S. and Winblad, B. Alzheimer's disease. Advances in etionlogy, pathogenesis and therapeutics. John Wiley & Sons, Ltd. 2001.
19 구진숙, 서부일, 박지하, 노성수. 치매 치료 한약(처방 및 한약재) 연구 논문 동향 분석. 大韓本草學會誌 25(3):131-137, 2010.
20 Skovronsky, D.M., Moore, D.B., Milla, M.E., Doms, R.W., Lee, V.M. Protein kinase C-dependent alpha-secretase competes with beta-secretase for cleavage of amyloid-beta precursor protein in the trans-golgi network. J. Biol. Chem. 275: 2568-2575, 2000.   DOI   ScienceOn
21 Nunan, J., Small, D.H. Regulation of APP cleavage by alpha-, beta- and gamma-secretases. FEBS Lett. 483: 6-10, 2000.   DOI   ScienceOn
22 Citron, M., Westaway, D., Xia, W., Carlson, G., Diehl, T., Levesque, G., Johnson-Wood, K., Lee, M., Seubert, P., Davis, A., Kholodenko, D., Motter, R., Sherrington, R., Perry, B., Yao, H., Strome, R., Lieberburg, I., Rommens, J., Kim, S., Schenk, D., Fraser, P., St George Hyslop, P. and Selkoe. D.J. Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice. Nat. Med. 3: 67-72, 1997.   DOI   ScienceOn
23 Obregon, D., Hou, H., Deng, J., Giunta, B., Tian, J., Darlington, D., Shahaduzzaman, M., Zhu, Y., Mori, T., Mattson, M.P., Tan, J. Soluble amyloid precursor protein-$\alpha$ modulates $\beta$-secretase activity and amyloid-$\beta$ generation. Nat Commun. 3: 777, 2012.   DOI   ScienceOn
24 Kang, J., Lemaire, H.G., Unterbeck, A., Salbaum, J.M., Masters, C.L., Grzeschik, K.H., Multhaup, G., Beyreuther, K., Muller-Hill, B. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 325: 733-736, 1987.   DOI   ScienceOn
25 Vellas, B. and Fitten, L.J. Research and practice in Alzheimer's disease. Springer Publishing Co. 2000.
26 Morris, J.C. Classification of dementia and Alzheimer's disease. Acta Neurol. Scand. 165: 41-50, 1996.
27 Braak, H., Braak, E. and Strothjohann, M. Abnormally phosphorylated tau protein related to the formation of neurofibrillary tangles and neuropil threads in the cerebral cortex of sheep and goat. Neurosci Lett. 171: 1-4, 1994.   DOI   ScienceOn